Maider Medical Industry Equipment Co. Ltd Class A

Maider Medical Industry Equipment Co. Ltd Class A

SSSE:688310
12.81
CNY
-0.26
(-1.99%)
0.17EPS
43.98P/E
2.53BMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.11
1.21
1.24
1.16
1.41
1.74
1.67
1.61
1.92
2.33
2.93
1.65
2.76
2.99
Basic EPS, GAAP
0.2
0.21
0.28
0.19
0.45
0.45
0.37
0.36
0.39
0.41
0.61
-0.12
0.4
0.35
Free Cash Flow per Basic Share
-0.07
-0.13
- -
0.31
0.56
0.21
-0.14
0.02
-0.17
-0.23
0.24
-0.18
0.6
- -
Dividend per Share
- -
0.01
0.01
0.43
- -
0.25
0.41
0.18
0.25
0.19
0.25
0.35
0.01
0.35
Book Value per Share
0.77
0.97
1.23
1.41
1.86
2.06
4.32
4.5
4.66
4.98
5.41
4.87
5.19
4.72
Tangible Book Value per Share
0.63
0.85
1.11
1.29
1.75
1.94
4.05
4.24
4.41
4.67
5.05
4.59
4.91
4.45
Basic Weighted Avg Shares
118
117
117
121
123
123
126
163
164
165
164
167
162
162
Sales/Revenue/Turnover
131
141
145
139
173
215
210
263
316
383
480
275
447
484
Operating Margin (%)
19.79
18.68
19.67
15.7
36.97
30.48
26.13
27.33
20.72
20.35
25.62
-8.48
12.49
8.84
Depreciation Expense
6
8
7
7
7
6
6
6
7
16
29
32
35
- -
Net Income, GAAP
23
25
32
23
56
56
47
59
64
67
100
-20
65
57
Effective Tax Rate (%)
13.31
13.04
12.88
16.98
14.85
13.54
13.92
15.24
9.23
11.69
13.99
- -
26.87
37.7
Profit Margin (%)
17.91
17.34
22.24
16.78
32.21
26.06
22.31
22.45
20.44
17.48
20.79
-7.27
14.51
11.7
Working Capital
9
40
77
106
166
196
624
596
508
443
530
446
471
354
LT Debt
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
30
56
57
Total Equity
94
119
151
173
229
253
707
736
763
830
940
845
875
771
Return on Invested Capital (%)
- -
15.82
12.79
7.74
24.92
22.66
8.95
7.95
8.29
9.7
12.52
- -
4.82
3.31
Return on Capital (%)
- -
19.76
20.52
13.64
27.19
23.13
9.76
8.18
8.66
7.16
10.17
- -
9.54
10.28
Return on Common Equity (%)
- -
23.03
23.88
14.46
27.82
23.24
9.73
8.18
8.59
8.47
11.66
-2.35
7.77
7.25

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
7
5
7
LT Borrowings
46
49
48
LT Finance Leases
10
11
9
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
166
166
164
Market Capitalization
2,548
2,512
2,526

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
709
628
587
Cash, Cash Equivalents & STI
386
290
254
Accounts Receivable, Net
91
73
62
Inventories
164
183
190
Total Current Liabilities
238
216
232
Payables & Accruals
- -
- -
- -
ST Debt
7
5
7
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
25.99%
3.84%
3.5%
Free Cash Flow
727.07%
-315.75%
-430.18%
Net Income, GAAP
-36.15%
-96.6%
-425.01%
Sales/Revenue/Turnover
15.44%
17.34%
62.79%
Total Cash Common Dividend
1,429.83%
-1.31%
-97.85%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
74
91
54
55
275
2025
40
101
- -
223
447
2026
40
120
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.06
- -
-0.01
-0.17
-0.12
2025
-0.07
0.1
- -
0.34
0.4
2026
-0.12
0.02
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.35
2025
- -
- -
- -
- -
0.01
2026
0.1
0.25
- -
- -
- -

Company Description

CEO
Jun Hua Lin
Full Time Employees
672
Sector
Distribution services
Industry
Medical distributors
Address
No.3 Tianyou Road Taizhou ZH China 317607
IPO Date
Dec 3, 2019
Business
Maider Medical Industry Equipment Co. Ltd. (688310.SS) engages in the research, development, production, sale, and service of intelligent automation equipment for medical consumables, primarily serving the healthcare equipment and supplies industry in China and internationally. Founded in 2003 and headquartered in Taizhou City, Zhejiang Province, China, the company offers comprehensive solutions including blood purification equipment such as automatic assembly machines for hemodialyzers, AV fistula needles, peritoneal dialysis pipelines, powder barrels, hollow fiber membrane spinning lines, hemoperfusion cartridges, pre-filled flushing syringes, and dialysis bloodlines; infusion solutions comprising automatic assembly machines for IV catheters and sets; transfusion solutions including disposable transfusion sets and leukocyte filters; biological reagents equipment like PCR automatic packaging systems; blood collection solutions for blood lancets, safety blood collection needles, and vacuum blood collection tubes; blood glucose solutions for insulin pens, pen needles, and syringes; in vivo intervention solutions for biopsy needles; respiration solutions for sputum suction catheters; anesthesia solutions for extension sets and spinal anesthesia needles; urinary system solutions for urinary catheters; and other combined products such as pre-filled and safety syringes, tube extrusion, and cutting machines. The company operates through three major business systems: intelligent equipment, IO4-enabled data management software, and process development, targeting global medical enterprises including Fresenius, Terumo, Shandong Weigao, and Kindly, with over 3,000 customized solutions delivered worldwide. In recent developments, Maider Medical reported a net loss in the first quarter of 2025 amid a 45.87% year-over-year revenue decline to 40.18 million yuan, announced a 38.6 million yuan capital increase for subsidiary Maideshun introducing new investors, completed a share repurchase of 2.09 million shares (1.26% of total capital) by January 2025, elected Lin Junhua as board chairman, and plans active participation in 2025 exhibitions including ME Expo, ARAB HEALTH, MEDICA, and COMPAMED to expand its medical automation presence.